151 related articles for article (PubMed ID: 15970584)
1. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.
Dekker LJ; Boogerd W; Stockhammer G; Dalebout JC; Siccama I; Zheng P; Bonfrer JM; Verschuuren JJ; Jenster G; Verbeek MM; Luider TM; Smitt PA
Mol Cell Proteomics; 2005 Sep; 4(9):1341-9. PubMed ID: 15970584
[TBL] [Abstract][Full Text] [Related]
2. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS.
Römpp A; Dekker L; Taban I; Jenster G; Boogerd W; Bonfrer H; Spengler B; Heeren R; Smitt PS; Luider TM
Proteomics; 2007 Feb; 7(3):474-81. PubMed ID: 17274072
[TBL] [Abstract][Full Text] [Related]
3. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
4. Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
Umar A; Dalebout JC; Timmermans AM; Foekens JA; Luider TM
Proteomics; 2005 Jul; 5(10):2680-8. PubMed ID: 15892168
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
[TBL] [Abstract][Full Text] [Related]
8. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) proteomic profiling of cerebrospinal fluid in the diagnosis of enteroviral meningitis: a proof-of-principle study.
Torres I; Giménez E; Vinuesa V; Pascual T; Moya JM; Alberola J; Martínez-Sapiña A; Navarro D
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2331-2339. PubMed ID: 30264355
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
10. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
[TBL] [Abstract][Full Text] [Related]
11. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
[TBL] [Abstract][Full Text] [Related]
12. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
13. Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors.
Pan Z; Yang G; Wang Y; He H; Pang X; Gao Y; Shi W; Li Y; Dong L; Song Y
PLoS One; 2015; 10(4):e0122016. PubMed ID: 25850010
[TBL] [Abstract][Full Text] [Related]
14. Novel methods to diagnose leptomeningeal metastases in breast cancer.
Angus L; Martens JWM; van den Bent MJ; Sillevis Smitt PAE; Sleijfer S; Jager A
Neuro Oncol; 2019 Mar; 21(4):428-439. PubMed ID: 30418595
[TBL] [Abstract][Full Text] [Related]
15. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
16. CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
Le Rhun E; Kramar A; Salingue S; Girot M; Rodrigues I; Mailliez A; Zairi F; Bakhache E; Robin YM; Taillibert S; Dubois F; Bonneterre J; Chamberlain MC
J Neurooncol; 2014 Mar; 117(1):117-24. PubMed ID: 24469852
[TBL] [Abstract][Full Text] [Related]
17. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.
Straathof CS; de Bruin HG; Dippel DW; Vecht CJ
J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979
[TBL] [Abstract][Full Text] [Related]
19. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides.
Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H
Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801
[TBL] [Abstract][Full Text] [Related]
20. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
